Agilent Technologies, Inc. (NYSE:A) Shares Sold by CENTRAL TRUST Co

Posted by Defense World Staff on Jul 3rd, 2023

CENTRAL TRUST Co trimmed its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 9.0% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 1,586 shares of the medical research company’s stock after selling 157 shares during the quarter. CENTRAL TRUST Co’s holdings in Agilent Technologies were worth $219,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in A. Synovus Financial Corp lifted its stake in Agilent Technologies by 2.3% in the first quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock valued at $895,000 after buying an additional 153 shares during the last quarter. Blair William & Co. IL raised its stake in shares of Agilent Technologies by 7.3% during the first quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company’s stock valued at $3,785,000 after purchasing an additional 1,957 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Agilent Technologies by 52.1% during the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock valued at $309,000 after purchasing an additional 799 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Agilent Technologies by 1.1% during the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock valued at $3,246,209,000 after purchasing an additional 261,435 shares in the last quarter. Finally, Zions Bancorporation N.A. raised its stake in shares of Agilent Technologies by 10.8% during the first quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock valued at $381,000 after purchasing an additional 281 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on A shares. 888 restated a “maintains” rating on shares of Agilent Technologies in a research note on Wednesday, May 24th. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 24th. Robert W. Baird cut their price objective on shares of Agilent Technologies from $174.00 to $144.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 24th. 58.com restated a “maintains” rating on shares of Agilent Technologies in a research note on Wednesday, May 24th. Finally, Evercore ISI dropped their price target on shares of Agilent Technologies from $150.00 to $126.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 24th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $151.06.

Agilent Technologies Trading Up 1.9 %

NYSE:A opened at $120.25 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 1.71. Agilent Technologies, Inc. has a fifty-two week low of $113.02 and a fifty-two week high of $160.26. The stock’s 50-day moving average is $124.03 and its two-hundred day moving average is $137.95. The stock has a market cap of $35.52 billion, a PE ratio of 26.49, a price-to-earnings-growth ratio of 1.91 and a beta of 1.04.

Agilent Technologies (NYSE:A – Free Report) last released its earnings results on Tuesday, May 23rd. The medical research company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.01. The company had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 30.11% and a net margin of 19.19%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.13 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.61 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd will be issued a dividend of $0.225 per share. The ex-dividend date is Friday, June 30th. This represents a $0.90 annualized dividend and a dividend yield of 0.75%. Agilent Technologies’s dividend payout ratio is 19.82%.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.